Literature DB >> 16823872

Importance of patient examination to clinical quality assurance in head and neck radiation oncology.

David I Rosenthal1, Joshua A Asper, Jerry L Barker, Adam S Garden, K S Clifford Chao, William H Morrison, Randal S Weber, K Kian Ang.   

Abstract

BACKGROUND: When quality assurance programs in clinical radiation oncology focus mainly on the technical aspects of treatment, they tend to underplay questions of therapeutic process and outcome. We determined the value of clinical peer review in radiation therapy for head and neck cancer that involved head and neck examination.
METHODS: Data were collected prospectively on 134 consecutive patients with preliminary radiation therapy (RT) plans. Peer review was performed that included head and neck examination and imaging review to confirm target localization.
RESULTS: Peer review led to changes in treatment plans for 66% of patients. Most changes were minor, but 11% of changes were major and thought to be of a magnitude that could potentially affect therapeutic outcome or normal tissue toxicity. Most changes involved target delineation based on physical findings
CONCLUSIONS: Peer review of radiation target localization in RT plans led to changes that could potentially affect rates of cancer control or complication in about 10% of patients. We suggest that the accuracy of head and neck radiation oncology treatment plans might be increased by co-examination by another head and neck cancer specialist, typically a radiation oncologist or head and neck surgeon, to confirm RT target volumes.

Entities:  

Mesh:

Year:  2006        PMID: 16823872     DOI: 10.1002/hed.20446

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  25 in total

1.  Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation.

Authors:  S Braunstein; C M Glastonbury; J Chen; J M Quivey; S S Yom
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

2.  High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study.

Authors:  G Brandon Gunn; Tito R Mendoza; Clifton D Fuller; Ibrahima Gning; Steven J Frank; Beth M Beadle; Ehab Y Hanna; Charles Lu; Charles S Cleeland; David I Rosenthal
Journal:  Head Neck       Date:  2012-11-20       Impact factor: 3.147

3.  Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.

Authors:  David I Rosenthal; Abdallah S R Mohamed; Randal S Weber; Adam S Garden; Parag R Sevak; Merril S Kies; William H Morrison; Jan S Lewin; Adel K El-Naggar; Lawrence E Ginsberg; Esengul Kocak-Uzel; K Kian Ang; Clifton David Fuller
Journal:  Cancer       Date:  2015-01-13       Impact factor: 6.860

4.  Quality initiatives in head and neck cancer.

Authors:  Amy Y Chen
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

5.  Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.

Authors:  G Brandon Gunn; Pierre Blanchard; Adam S Garden; X Ronald Zhu; C David Fuller; Abdallah S Mohamed; William H Morrison; Jack Phan; Beth M Beadle; Heath D Skinner; Erich M Sturgis; Merrill S Kies; Kate A Hutcheson; David I Rosenthal; Radhe Mohan; Michael T Gillin; Steven J Frank
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-12       Impact factor: 7.038

6.  Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.

Authors:  Pierre Blanchard; Andrew J Wong; G Brandon Gunn; Adam S Garden; Abdallah S R Mohamed; David I Rosenthal; Joseph Crutison; Richard Wu; Xiaodong Zhang; X Ronald Zhu; Radhe Mohan; Mayankkumar V Amin; C David Fuller; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-09-15       Impact factor: 6.280

7.  Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.

Authors:  David I Rosenthal; Tito R Mendoza; Clifton D Fuller; Katherine A Hutcheson; X Shelley Wang; Ehab Y Hanna; Charles Lu; Adam S Garden; William H Morrison; Charles S Cleeland; G Brandon Gunn
Journal:  Cancer       Date:  2014-04-07       Impact factor: 6.860

8.  Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.

Authors:  Panayiotis Mavroidis; Drosoula Giantsoudis; Musaddiq J Awan; Jasper Nijkamp; Coen R N Rasch; Joop C Duppen; Charles R Thomas; Paul Okunieff; William E Jones; Lisa A Kachnic; Niko Papanikolaou; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2014-07-01       Impact factor: 6.280

9.  Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.

Authors:  Pierre Blanchard; Adam S Garden; G Brandon Gunn; David I Rosenthal; William H Morrison; Mike Hernandez; Joseph Crutison; Jack J Lee; Rong Ye; C David Fuller; Abdallah S R Mohamed; Kate A Hutcheson; Emma B Holliday; Nikhil G Thaker; Erich M Sturgis; Merrill S Kies; X Ronald Zhu; Radhe Mohan; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-06-21       Impact factor: 6.280

10.  Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy.

Authors:  Qiuling Shi; Tito R Mendoza; G Brandon Gunn; Xin Shelley Wang; David I Rosenthal; Charles S Cleeland
Journal:  Qual Life Res       Date:  2013-03-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.